Trade Summary

1 week ago, Cowan Elvia, serving as SVP, Finance at Vaxcyte, Inc. (PCVX), sold 11,623 shares at $47.92 per share, for a total transaction value of $556,972.00. Following this transaction, Cowan Elvia now holds 13,534 shares of PCVX.

This sale represents a 46.00% decrease in Cowan Elvia's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, December 23, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 6 days after the trade was made.

Vaxcyte, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.